A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase.
Oxygen-derived free radicals play an important role in the myocardial injury associated with ischemia and reperfusion. This study was designed to assess whether the protection afforded by a K+ rich, Mg2+ rich cardioplegic solution could be enhanced by the addition of free radical scavengers acting at different levels of the radical generating pathway. Forty isolated isovolumic rat hearts were divided into five groups (n = 8). Four groups of hearts were subjected to 90 minutes of normothermic cardioplegic arrest followed by 45 minutes of reperfusion. Hearts were given an initial bolus of either unmodified cardioplegic solution or cardioplegic solution enriched with superoxide dismutase (200,000 U/L) reduced glutathione (0.1 mmol/L), or peroxidase (6,000 U/L). One group of hearts was aerobically perfused throughout the experimental protocol and served as nonischemic controls. Based on comparisons of postreperfusion ventricular pressure development, maximal ventricular dP/dt, left ventricular compliance and coronary flow, peroxidase-containing cardioplegic solution afforded the best myocardial protection, with values of these indicators not significantly different from those of nonischemic perfused control heart. Glutathione afforded protection slightly inferior to that of peroxidase but still markedly better than in groups receiving superoxide dismutase or unmodified cardioplegic solution. This study confirms that cardioplegic protection can be enhanced by the addition of free radical scavengers, in particular peroxidase.
D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures; D003326:Coronary Circulation; D005609:Free Radicals; D006352:Heart Ventricles / Q000187:drug effects; D007527:Isoenzymes / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D009195:Peroxidase; D010544:Peroxidases / Q000378:metabolism; D011343:Procaine / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013012:Sorbitol / Q000494:pharmacology / Q000627:therapeutic use*; D013482:Superoxide Dismutase / Q000494:pharmacology / Q000627:therapeutic use; D016276:Ventricular Function
D005609:Free Radicals; D007527:Isoenzymes; D001224:Aspartic Acid; D011343:Procaine; D013012:Sorbitol; C006915:Cardioplegin; D010544:Peroxidases; D009195:Peroxidase; D013482:Superoxide Dismutase; D010100:Oxygen